CNS and Ageing Delegates

Who should attend?
This event is targeted to involve those experts in the following functions:
• CEO company executives
• Research directors and group leaders
• Investors
• Business development executives
• Academic and clinical researchers
• Regulators
• Professional service advisors
Please allow 5 working days from payment of your registration to receive your partnering login details.
Any partnering login queries please contact Oliver Muncey at One Nucleus oliver@onenucleus.com
Companies registered for this event are;
Abcam plc
AMRI
Apitope Technology (Bristol) Ltd
Aptuit Ltd
Argenta Discovery 2009 Ltd
Armorfix Life Sciences
AstraZeneca
Babraham Institute
biOasis Technologies
biocrea GmbH
BioFocus
BioPark
Biotica Technology Ltd
Biotie Therapies
Cambridge Enterprise University of Cambridge
Cambridge Judge Business School
Canadian High Commission
Canadian Institute of Health Research (CIHR)
CenTRion Therapeutics Ltd
Convergence Pharmaceuticals Ltd
Development Chemicals Limited
Edinburgh BioQuarter
Eolas Biosciences Ltd
ERA Consulting (UK) Ltd
GE Healthcare
Heptares Therapeutics
Huntingdon Life Sciences
ICON Development Solutions
InterVivo Solutions
Ixico Ltd
Eli Lilly and Co.
Marks and Clerk
Massachusetts Life Sciences Center
MedImmune Ltd
Melbourn Scientific Ltd
Merck & Co Inc
Mewburn Ellis LLP
MRC Technology
MS Therapeutics Limited
Nansen Neuroscience Network
NextGen Sciences
One Nucleus
Oxbridge Biotechnology Roundtable
Parexel International
Peakdale Molecular Ltd
Pharmidex Pharmaceutical Services Ltd
Phytopharm plc
Proximagen Limited
QCTR Ltd
QPS (UK)
Quebec Bio-Imaging Network
Quebec Government Office
Quotient Bioresearch Ltd
Reddie & Grose LLP
Ricerca Biosciences
The Severnside Alliance for Translational Research (SARTRE)
Schwartz MSL
Selcia Limited
Senexis Limited
Spectrum Regulatory Solutions
Surrey Clinical Research Centre
Sygnature Discovery Ltd
Taylor Wessing
The Ann Hayes Consultancy Ltd
The Ontario Brain Institute
UK Trade & Investment
University College London - Institute of Neurology
University of Sheffield
Zoragen Biotechnologies
Cost of participation:
One Nucleus Gold Member £175 + VAT
One Nucleus Silver Member £295 + VAT
Non-member £420 + VAT
This event is targeted to involve those experts in the following functions:• CEO company executives• Research directors and group leaders• Investors• Business development executives• Academic and clinical researchers• Regulators• Professional service advisorsOne Nucleus Gold Member £175 + VATOne Nucleus Silver Member £295 + VATNon-member £420 + VAT
Further information
To download the delegate manual please click here
Tony Jones Ph.D
Director of Business Development
+44 (0) 1223 896 463 – Direct
+44 (0) 7852030307 - Mobile
+44 (0) 1223 896 450 – Main Office
www.onenucleus.com